Literature DB >> 10484481

Time-dependent hypoxic ventilatory responses in rats: effects of ketanserin and 5-carboxamidotryptamine.

R Kinkead1, G S Mitchell.   

Abstract

We hypothesized that the 5-hydroxytryptamine (5-HT) active drugs ketanserin and 5-carboxamidotryptamine (5-CT) would modulate time-dependent hypoxic phrenic and hypoglossal responses, including 1) short-term hypoxic response, 2) posthypoxia frequency decline (PHFD), and 3) long-term facilitation (LTF) of respiratory motor output. Phrenic and hypoglossal nerve activities were recorded in urethan-anesthetized, paralyzed, vagotomized, and artificially ventilated rats pretreated either with ketanserin (5-HT(2A/C) antagonist; 2 mg/kg iv), 5-CT (5-HT(1A/B) agonist; 10 microg/kg iv), or saline (sham). Rats were exposed to three 5-min episodes of hypoxia [fractional inspired O(2) (FI(O2)) = 0.11], separated by 5 min of hyperoxia (FI(O2) = 0.5). During hypoxia, ketanserin augmented phrenic but not hypoglossal burst amplitude; 5-CT had no effect. Both drugs accentuated PHFD. Ketanserin blocked phrenic LTF; hypoglossal LTF was not apparent, even in sham-treated rats. 5-CT reversed LTF, resulting in a long-lasting depression of phrenic burst frequency and amplitude without effect on hypoglossal burst amplitude. The data suggest that 1) 5-HT(2A/C) receptor activation modulates the short-term hypoxic phrenic response and PHFD and is necessary for LTF; and 2) 5-CT may affect time-dependent hypoxic ventilatory responses by reducing serotonin release via 5-HT(1A/B) autoreceptor activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484481     DOI: 10.1152/ajpregu.1999.277.3.R658

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  38 in total

1.  Episodic but not continuous hypoxia elicits long-term facilitation of phrenic motor output in rats.

Authors:  T L Baker; G S Mitchell
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

2.  Severe acute intermittent hypoxia elicits phrenic long-term facilitation by a novel adenosine-dependent mechanism.

Authors:  Nicole L Nichols; Erica A Dale; Gordon S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2012-03-08

3.  Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats.

Authors:  N L Nichols; R A Johnson; I Satriotomo; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2014-03-28       Impact factor: 1.931

4.  Spinal nNOS regulates phrenic motor facilitation by a 5-HT2B receptor- and NADPH oxidase-dependent mechanism.

Authors:  P M MacFarlane; S Vinit; G S Mitchell
Journal:  Neuroscience       Date:  2014-03-26       Impact factor: 3.590

5.  Chronic intermittent hypoxia elicits serotonin-dependent plasticity in the central neural control of breathing.

Authors:  L Ling; D D Fuller; K B Bach; R Kinkead; E B Olson; G S Mitchell
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

6.  Spinal activation of protein kinase C elicits phrenic motor facilitation.

Authors:  Michael J Devinney; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2017-11-02       Impact factor: 1.931

7.  Long term facilitation of respiratory motor output decreases with age in male rats.

Authors:  A G Zabka; M Behan; G S Mitchell
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

Review 8.  NADPH oxidase activity is necessary for acute intermittent hypoxia-induced phrenic long-term facilitation.

Authors:  P M MacFarlane; I Satriotomo; J A Windelborn; G S Mitchell
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

9.  Determinants of frequency long-term facilitation following acute intermittent hypoxia in vagotomized rats.

Authors:  Tracy L Baker-Herman; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2008-03-18       Impact factor: 1.931

10.  Microinjection of methysergide into the raphe nucleus attenuated phrenic long-term facilitation in rats.

Authors:  Maja Valic; Renata Pecotic; Ivana Pavlinac; Zoran Valic; Kristina Peros; Zoran Dogas
Journal:  Exp Brain Res       Date:  2010-01-20       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.